6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Apr 2026
- Reporting date
- 13 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,818 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 101-125 of 1,000 matching filings.
Per page
25
Current page
5
6-K
File 001-15170
GSK PRESENTS POSITIVE DATA FOR BEHOLD 1 B7 H4 ADC
- Filing date
- 13 Apr 2026
- Reporting date
- 13 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 13 Apr 2026
- Reporting date
- 13 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 10 Apr 2026
- Reporting date
- 10 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 10 Apr 2026
- Reporting date
- 10 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 09 Apr 2026
- Reporting date
- 09 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 09 Apr 2026
- Reporting date
- 09 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
EXDENSUR APPROVED FOR CRSWNP IN CHINA
- Filing date
- 08 Apr 2026
- Reporting date
- 08 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 08 Apr 2026
- Reporting date
- 08 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 07 Apr 2026
- Reporting date
- 07 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 02 Apr 2026
- Reporting date
- 02 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 01 Apr 2026
- Reporting date
- 01 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Apr 2026
- Reporting date
- 01 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 01 Apr 2026
- Reporting date
- 01 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
VIIV COMPLETES CHANGES TO MINORITY SHAREHOLDING
- Filing date
- 01 Apr 2026
- Reporting date
- 01 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 31 Mar 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BEPIROVIRSEN ACCEPTED FOR REVIEW IN CHINA
- Filing date
- 30 Mar 2026
- Reporting date
- 30 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
EXDENSUR APPROVED FOR SEVERE ASTHMA IN CHINA
- Filing date
- 30 Mar 2026
- Reporting date
- 30 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 30 Mar 2026
- Reporting date
- 30 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 27 Mar 2026
- Reporting date
- 27 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BEPIROVIRSEN ACCEPTED FOR REVIEW BY THE EMA
- Filing date
- 27 Mar 2026
- Reporting date
- 27 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 26 Mar 2026
- Reporting date
- 26 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 25 Mar 2026
- Reporting date
- 25 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
NOTICE OF AGM
- Filing date
- 25 Mar 2026
- Reporting date
- 25 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 25 Mar 2026
- Reporting date
- 25 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing